Jan Pinkas
Chief Scientific Officer at Crescent Biopharma, Inc. (CBIO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $35K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 18SEC | CBIOCrescent Biopharma, Inc. | Sell Plan | 65821,581 held (−3%) | $17.90 | $12K | -33.9% |
| Jun 23SEC | CBIOCrescent Biopharma, Inc. | Sell Plan | 1,28822,239 held (−5%) | $17.99 | $23K | -34.2% |
- Sell
Chief Scientific Officer Jan Pinkas sold $12K of CBIO at $17.90 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jan Pinkas sold $23K of CBIO at $17.99 — pre-scheduled 10b5-1 plan sale.